Latest Articles
- The role of aldosterone receptor antagonists in the management of heart failure: An update
Spironolactone (Aldactone) and eplerenone (Inspra) are now part of standard therapy. Still, they must be used cautiously, as they can cause hyperkalemia.
- The apples and oranges of cost-effectiveness: A rejoinder
A recent CCJM commentary used straw men to indict cost-effectiveness research.
- An argument for reviving the disappearing skill of cardiac auscultation
Three case scenarios show how the clinical examination can complement echocardiography in the evaluation of valvular heart disease.
- In reply: Synthetic legal intoxicating drugs
Readers comment on synthetic legal intoxicating drugs (April 2012) and on the geriatric patient-centered medical home (May 2012).
- Autoinflammatory syndromes: Fever is not always a sign of infection
Our growing understanding of genetics and the immune system has unearthed a number of syndromes characterized by recurrent fevers that mimic malignancy or infection.
- Genetic counselors: Your partners in clinical practice
As our understanding of the human genome has grown, so too has the need for health care providers to help patients and families understand the implications of these discoveries.
- Distinguishing cellulitis from its mimics
Common imitators are stasis dermatitis, lipodermatosclerosis, contact dermatitis, lymphedema, eosinophilic cellulitis, and papular urticaria.
- Atrial fibrillation: New drugs, devices, and procedures
An update on controversies in treating atrial fi brillation: new oral anticoagulants vs warfarin, rate control vs rhythm control, the safety of dronedarone, and the efficacy of ablation.
- Synthetic legal intoxicating drugs
Readers comment on synthetic legal intoxicating drugs (April 2012) and on the geriatric patient-centered medical home (May 2012).